Transce3nd’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68K Buy
+10
New +$1.67K ﹤0.01% 495
2025
Q3
– Sell
-13
Closed -$1.75K – 230
2025
Q2
$1.75K Hold
13
– – ﹤0.01% 906
2025
Q1
$1.84K Sell
13
-1
-7% -$145 ﹤0.01% 873
2024
Q4
$1.77K Buy
+14
New +$1.96K ﹤0.01% 1121

Other funds holding AZN

Transce3nd's AZN Position: Q3 2026 in Review

Transce3nd opened a new position in AstraZeneca (AZN) in Q3 2026: 10 shares worth $1.68K. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings. This is a return to the name: Transce3nd previously reported a position in AZN as recently as Q2 2025.

Transce3nd first reported a position in AZN in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.84K in Q1 2025. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Transce3nd held 10 shares of AstraZeneca worth $1.68K as of Q3 2026.
  • AstraZeneca was a new Transce3nd position in Q3 2026.
  • AstraZeneca made up ﹤0.01% of Transce3nd's portfolio in Q3 2026, its #495 holding.
  • Transce3nd first reported a position in AstraZeneca in Q4 2024 and has held it in 4 quarters since.
  • Transce3nd's AstraZeneca position peaked at $1.84K in Q1 2025.
  • 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Transce3nd's 13F filing for Q3 2026, filed 26 Oct 2026.